We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$130M
AUM Growth
+$11.7M
Cap. Flow
+$893K
Cap. Flow %
0.69%
Top 10 Hldgs %
23.8%
Holding
95
New
6
Increased
26
Reduced
41
Closed
1

Top Sells

Rank Stock Value
1
AA icon
Alcoa
AA
+$398K
2
EFOR
Everforth Inc
EFOR
+$246K
3
MMM icon
3M
MMM
+$157K
4
GE icon
GE Aerospace
GE
+$156K
5
CL icon
Colgate-Palmolive
CL
+$144K

Sector Composition

Rank Sector Weight
1 Industrials 14.15%
2 Technology 13.24%
3 Consumer Staples 11.19%
4 Healthcare 10.81%
5 Financials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
51
State Street
STT
$48.4B
$1.07M 0.82%
14,576
-194
-1% -$13.6K
IAU icon
52
iShares Gold Trust
IAU
$62.8B
$1M 0.77%
42,870
-4,570
-10% -$113K
JNJ icon
53
Johnson & Johnson
JNJ
$640B
$974K 0.75%
10,640
AMLP icon
54
Alerian MLP ETF
AMLP
$12.9B
$944K 0.73%
10,621
+1,777
+20% +$156K
VEU icon
55
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$876K 0.67%
17,285
-350
-2% -$17.4K
AOR icon
56
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.61B
$868K 0.67%
22,562
+1,300
+6% +$49.1K
PG icon
57
Procter & Gamble
PG
$340B
$854K 0.66%
10,499
-400
-4% -$32.6K
HD icon
58
Home Depot
HD
$337B
$820K 0.63%
9,960
AMJ
59
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$768K 0.59%
16,585
-55
-0.3% -$2.48K
BBH icon
60
VanEck Biotech ETF
BBH
$406M
$737K 0.57%
8,328
-747
-8% -$62.5K
IBM icon
61
IBM
IBM
$213B
$636K 0.49%
3,551
-251
-7% -$43.3K
DUK icon
62
Duke Energy
DUK
$101B
$569K 0.44%
8,247
-184
-2% -$12.9K
PFE icon
63
Pfizer
PFE
$143B
$535K 0.41%
18,426
DIS icon
64
Walt Disney
DIS
$171B
$517K 0.4%
6,770
BXP icon
65
Boston Properties
BXP
$11.6B
$490K 0.38%
4,885
JPM icon
66
JPMorgan Chase
JPM
$916B
$424K 0.33%
7,266
-600
-8% -$32.9K
KMB icon
67
Kimberly-Clark
KMB
$37.6B
$407K 0.31%
4,068
-76
-2% -$7.58K
CTAS icon
68
Cintas
CTAS
$86.6B
$386K 0.3%
25,916
MRK icon
69
Merck
MRK
$322B
$367K 0.28%
7,695
PAYX icon
70
Paychex
PAYX
$43.4B
$358K 0.28%
7,875
SYK icon
71
Stryker
SYK
$135B
$354K 0.27%
4,724
PPG icon
72
PPG Industries
PPG
$24.9B
$350K 0.27%
3,700
BMY icon
73
Bristol-Myers Squibb
BMY
$129B
$332K 0.26%
6,260
-192
-3% -$9.78K
IVV icon
74
iShares Core S&P 500 ETF
IVV
$858B
$332K 0.26%
+1,790
New +$319K
YUM icon
75
Yum! Brands
YUM
$41.9B
$326K 0.25%
6,009

Similar funds

Boston Research & Management's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Research & Management held 95 positions worth $130M, up 9.9% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boston Research & Management's Q4 2013 filing shows 6 new, 26 increased, 41 reduced and 1 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,790 shares worth $332K. The largest sale was Alcoa, an estimated $398K.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q4 2013 buy was iShares Core S&P 500 ETF: 1,790 shares worth $332K.
  • Boston Research & Management added most to Cisco in Q4 2013, an estimated $339K increase.
  • Boston Research & Management's biggest Q4 2013 reduction was Alcoa, cutting an estimated $398K.
  • Boston Research & Management fully exited Everforth Inc in Q4 2013, selling an estimated $246K.
  • Boston Research & Management's ten largest holdings make up 24% of its $130M portfolio in Q4 2013.
  • Boston Research & Management opened 6 new positions and closed 1 in Q4 2013.
  • Boston Research & Management's portfolio value rose 9.9% quarter-over-quarter to $130M.

Based on Boston Research & Management's 13F filing for Q4 2013, filed 7 Feb 2014.